These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24298691)

  • 41. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates.
    Chan PC; Yang CH; Chang LY; Wang KF; Kuo YC; Lin CJ; Lee SW; Hsueh PR; Fang CT; Huang LM
    Thorax; 2013 Mar; 68(3):263-8. PubMed ID: 23019256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.
    Ahmadinejad Z; Azmoudeh Ardalan F; Razzaqi M; Davoudi S; Jafarian A
    Transpl Infect Dis; 2013 Feb; 15(1):90-5. PubMed ID: 23173720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients.
    Sayarlioğlu H; Gül M; Eren Dağli C; Doğan E; Sahin M; Uçar MA; Köksal N; Sayarlioğlu M; Tahta MK
    Tuberk Toraks; 2011; 59(2):105-10. PubMed ID: 21740383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada.
    Levesque JF; Dongier P; Brassard P; Allard R
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):711-7. PubMed ID: 15182140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.
    Chee CB; KhinMar KW; Gan SH; Barkham TM; Pushparani M; Wang YT
    Am J Respir Crit Care Med; 2007 Feb; 175(3):282-7. PubMed ID: 17082492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].
    Komukai J; Matsumoto K; Tomihara A; Miyake Y; Tatsumi T; Arima K; Danno K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):847-56. PubMed ID: 22250463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.
    Sandgren A; Vonk Noordegraaf-Schouten M; van Kessel F; Stuurman A; Oordt-Speets A; van der Werf MJ
    BMC Infect Dis; 2016 May; 16():204. PubMed ID: 27184748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey.
    Shieh FK; Snyder G; Horsburgh CR; Bernardo J; Murphy C; Saukkonen JJ
    Am J Respir Crit Care Med; 2006 Sep; 174(6):717-21. PubMed ID: 16809632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exaggerated Mantoux reaction in a case of latent tuberculosis infection (LTBI).
    Bansal R; Sharma PK
    Indian J Tuberc; 2012 Jul; 59(3):171-3. PubMed ID: 23362716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
    Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D
    Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent trends in the incidence of latent tuberculosis infection in Japanese patients with lung cancer: A small retrospective study.
    Tamura A; Fukami T; Hebisawa A; Takahashi F
    J Infect Chemother; 2020 Mar; 26(3):315-317. PubMed ID: 31787530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy of the treatment for latent tuberculosis infection and delayed reactivation of tuberculosis].
    Toyota M
    Kekkaku; 2013 Sep; 88(9):667-70. PubMed ID: 24298693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Investigation of a new treatment outcome index for tuberculosis].
    Ito K
    Kekkaku; 2014 Sep; 89(9):731-6. PubMed ID: 25730944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing the initiation and adherence of LTBI treatment in healthcare workers: a systematic review.
    Yang H; Park H
    Arch Environ Occup Health; 2022; 77(1):76-86. PubMed ID: 34184972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.